This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

3 May 2011

FDA & IPEC Work on Excipient Screening

The screening programme is to improve the efficiency of the FDA's monitoring and surveillance of the pharmaceutical supply chain.

In an attempt to speed up its monitoring and surveillance of the pharma supply chain, the FDA has approached industry group IPEC Americas for help with excipient authentication. The goal is to develop a quick first-level screen that can identify samples requiring further screening.


For the initial screen, FDA inspectors would use portable devices based on X-ray and various spectroscopy technologies. They will look for metals and other contaminants, but also will compare scan results against spectra from known-good excipients. The authentic spectra database will be supplied by IPEC's Excipient Qualification Committee.

Related News